Biohaven Ltd. Common Shares (BHVN) earnings
BHVN earnings moved a median of -5.35% by the close. Quarterly and annual BHVN reports and results, each read against the price at its own news timestamp. Back to the BHVN overview →
19 measured BHVN earnings events.
Where these BHVN earnings landedvs 18 measured BHVN earnings reactions
| Middle 50% of BHVN earnings reactions | -7.15% to -2.53% |
|---|---|
| Median reaction (to close) | -5.35% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 BHVN earnings events with a measured close landed between -7.15% and -2.53%; 11% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results | Press release | +5.47% | -4.33% | |
| Form 10-Q Biohaven Ltd. For: Mar 31 | SEC filing · Form 10-Q | +5.47% | -4.33% | |
| Form 10-K Biohaven Ltd. For: Dec 31 | SEC filing · Form 10-K | -2.90% | -7.46% | |
| Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments | Press release | -1.62% | -7.81% | |
| Form 10-Q Biohaven Ltd. For: Sep 30 | SEC filing · Form 10-Q | -1.62% | -7.81% | |
| Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments | Press release | -6.71% | -6.22% | |
| Form 10-Q Biohaven Ltd. For: Jun 30 | SEC filing · Form 10-Q | -0.66% | — | |
| Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments | Press release | -2.55% | -5.98% | |
| Form 10-Q Biohaven Ltd. For: Mar 31 | SEC filing · Form 10-Q | -2.55% | -5.98% | |
| Form 10-K Biohaven Ltd. For: Dec 31 | SEC filing · Form 10-K | -10.00% | -0.76% | |
| Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments | Press release | -0.87% | -5.35% | |
| Form 10-Q Biohaven Ltd. For: Sep 30 | SEC filing · Form 10-Q | -0.87% | -5.35% | |
| Form 10-Q Biohaven Ltd. For: Jun 30 | SEC filing · Form 10-Q | +0.82% | -4.84% | |
| Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments | Press release | +2.32% | +7.61% | |
| Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments | Press release | -1.17% | -11.04% | |
| Form 10-Q Biohaven Ltd. For: Mar 31 | SEC filing · Form 10-Q | -1.17% | -11.04% | |
| Form 10-K Biohaven Ltd. For: Dec 31 | SEC filing · Form 10-K | +1.33% | +4.34% | |
| Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments | Press release | -2.68% | -1.92% | |
| Form 10-Q Biohaven Ltd. For: Sep 30 | SEC filing · Form 10-Q | -2.68% | -1.92% |
Keep exploring
More BHVN: analyst actions → · SEC filings → · BHVN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Geron Corporation (GERN) | 949 | -0.28% | 41% |
| Intellia Therapeutics, Inc. (NTLA) | 948 | -0.24% | 45% |
| GW PHARMACEUTICALS PLC AMERICA (GWPH) | 942 | -0.06% | 47% |
| Intersect ENT, Inc. (XENT) | 937 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.